These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36039212)

  • 1. Chronic Pulmonary Aspergillosis During Convalescence From Severe COVID-19 Treated With Oral Itraconazole: A Report of Two Cases.
    Horiuchi H; Utada S; Shinomiya Y; Miyagawa T; Sogo A; Niida S; Okano H; Suzuki N; Otsuka T; Miyazaki H; Furuya R
    Cureus; 2022 Jul; 14(7):e27281. PubMed ID: 36039212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
    Tashiro M; Takazono T; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Kakeya H; Ando T; Ogawa K; Kishi K; Tokimatsu I; Hayashi Y; Fujiuchi S; Yanagihara K; Miyazaki Y; Ichihara K; Mukae H; Kohno S; Izumikawa K
    Clin Infect Dis; 2020 Feb; 70(5):835-842. PubMed ID: 30959519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease: A cross-sectional study.
    Suzuki S; Asakura T; Namkoong H; Okamori S; Yagi K; Kamata H; Uwamino Y; Funatsu Y; Nakano Y; Nishimura T; Ishii M; Ebihara T; Betsuyaku T; Hasegawa N
    Respir Med; 2018 May; 138():1-6. PubMed ID: 29724379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cavitary pulmonary aspergillosis in an immunocompetent child.
    Davies AA; Adegbite IA; Akintan PE; Ibrahim UO; Adekoya AO; Oladele RO
    Med Mycol Case Rep; 2022 Sep; 37():33-36. PubMed ID: 35865451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
    Chong WH; Saha BK; Neu KP
    Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
    Nasir N; Farooqi J; Mahmood SF; Jabeen K
    Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
    Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
    Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Associated Pulmonary Aspergillosis: A Case Series.
    Yulianti M; Johan C; Tenda ED; Singh G; Herikurniawan H; Wijaya IPEK
    Acta Med Indones; 2022 Apr; 54(2):292-298. PubMed ID: 35818652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 associated pulmonary aspergillosis with extensive cavitary pneumonia: A case report.
    Hanif S; Iqbal M; Sethi SM
    J Pak Med Assoc; 2023 Jan; 73(1):174-176. PubMed ID: 36842034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
    Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
    Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary aspergillosis: diagnosis and treatment.
    Lamoth F; Calandra T
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36450372
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
    Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
    Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
    Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
    BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements.
    Montrucchio G; Lupia T; Lombardo D; Stroffolini G; Corcione S; De Rosa FG; Brazzi L
    Ann Intensive Care; 2021 Sep; 11(1):136. PubMed ID: 34524562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19].
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim; 2022 Jan; 69(1):48-53. PubMed ID: 33994593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
    Shirai T; Furuuchi K; Fujiwara K; Nakamoto K; Tanaka Y; Ishii H; Yoshiyama T; Yoshimori K; Takizawa H; Sasaki Y; Kurashima A; Ohta K; Morimoto K
    Respir Med; 2020 May; 166():105955. PubMed ID: 32321630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.